Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
40S ribosomal protein S19 (RPS19) is a highly conserved ribosomal protein that forms part of the small (40S) subunit of the eukaryotic ribosome. RPS19 is essential for the assembly, structural stability, and function of the small ribosomal subunit, including facilitating pre-rRNA processing and export of the 40S subunit from the nucleus to the cytoplasm. It interacts mainly with 18S ribosomal RNA and other ribosomal proteins to form the ribosome. Mutations in the RPS19 gene are the most common cause of Diamond-Blackfan anemia, a congenital disorder of erythroid lineage bone marrow failure and various developmental abnormalities. Some evidence suggests RPS19 may also participate in cell cycle regulation, apoptosis, and is overexpressed in some cancers (e.g., colon carcinoma); additionally, it has been observed to interact with factors such as basic fibroblast growth factor and may play an extra-ribosomal role, including involvement in immune signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 40S ribosomal protein S19 (RPS19).